Location: Home /  About MGI

MGI Tech Initiated APAC SEQ ALL Alliance to Foster Industrial Co-development in Genomics

Release date:2025-04-29Writer:MGIViews:300Share

Bali, Indonesia, 29 April 2025 - MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, recently announced the founding of the APAC SEQ ALL Alliance, established during the MGI APAC SEQ ALL Partner Summit (Summit) in Bali, Indonesia. The founding members of the alliance involves leading institutions in Asia-Pacific region, including Gene Solutions, GenePlus, Genecast, Genskey, Genetron, Longlight, Nanodigmbio. Alongside the recognition ceremony held during the Summit hosted by MGI, this collaborative initiative aims to create an open, integrated and shared ecosystem for sequencing technologies across the Asia-Pacific. Additionally, MGI unveiled its new bio-fragment analyzer, the FragQ series, and showcased several flagship products, including the latest mid-throughput sequencer, the DNBSEQ-T1+. 


Promote Co-efficiency of Genomic Sequencing in APAC

As genomic sequencing technologies continue to evolve rapidly, the Asia-Pacific region is encountering pressing challenges, including fragmented applications, inefficient collaboration, and significant data silos. The APAC SEQ ALL Alliance, initiated by MGI Tech in partnership with several regional leaders, aims to address these challenges and promote regional synergy. The alliance will focus on enhancing compatibility across sequencing platforms, automation systems, and supporting products, enabling seamless integration among diverse legacy systems. Furthermore, the alliance is committed to accelerating the translation of genomic innovations into real-world applications, particularly in critical areas such as clinical diagnostics, public health, and agriculture.

 

Dr. Roy Tan, General Manager of MGI APAC, stated, The founding of the APAC SEQ ALL Alliance marks a significant milestone in our journey to transform the landscape of genomic research and application in the Asia-Pacific region. By fostering collaboration and innovation across institutions, we can collectively tackle the challenges we face, drive scientific breakthroughs, and ultimately improve health outcomes for communities across the region.


Advancing Life Science with Innovations

During the Summit, MGI launched the FragQ series of bio-fragment analyzers, which includes the FragQ-S18 designed for small to mid-throughput applications and the FragQ-S100 tailored for high-throughput and large-scale projects, both adaptable to various sample volumes. 


FragQ-S18

Featuring an innovative disposable gel-cartridge capable of handling 100 to 200 samples without gel preparation, the FragQ Series aims to sets a new standard for ease of use in nucleic acid quality control by replacing complicated, time-consuming gel electrophoresis workflows. The FragQ series are capable of delivering fragment analysis results in as fast as 2–7 minutes per sample with minimal hands-on time, addressing the growing demand for fast, accurate, and scalable quality control in today's genomics-driven world. With high resolution (1–4 bp for fragments under 500 bp) and exceptional sensitivity (as low as 5 pg/μL), the FragQ series ensures highly accurate, reproducible results with significantly faster preparation and analysis time compared to traditional methods.

 

The DNBSEQ-T1+, the flagship mid-throughput sequencer recently introduced to Japan market, also made its presence at the Summit to bring unparalleled sequencing experience to the alliance. Capable of executing a paired-end 150 sequencing workflow in just 24 hours with Q40 accuracy, the DNBSEQ-T1+ stands out for its efficiency, flexibility and versatility that supports a wide range of applications across various research fields.

 

By leveraging proprietary sequencing technology and automation intelligence, MGI is committed to empowering researchers and institutions to overcome challenges in the life sciences. With the introduction of innovative products like the FragQ series and the DNBSEQ-T1+, MGI is poised to lead the industry toward transformative advancements in healthcare, research, and beyond.

 

For more information about MGI APAC SEQ ALL Alliance and product information, please visit  https://en.mgi-tech.com/ or contact MGI-service@mgi-tech.com.

  • Hotline (Global)
    +86-4000-688-114
  • Email
    MGI-service@mgi-tech.com
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Copyright © 2025 All Rights Reserved MGI Tech Co., Ltd. Guangdong ICP 16117185Privacy PolicyLegal NoticesCookie Policy
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies